期刊文献+

根除幽门螺杆菌治疗方案疗效对比 被引量:2

下载PDF
导出
摘要 目的:研究不同方案根除幽门螺杆菌临床疗效。方法:将75例患者随机分为两组,莫西沙星组39例患者给予埃索美拉唑、莫西沙星、奥硝唑,克拉霉素组36例患者给予埃索美拉唑、阿莫西林、克拉霉素,治疗1周后比较治愈率和幽门螺杆菌根治率,对于根治失败组采取再治疗,观察治疗效果。结果:莫西沙星组有效率显著高于克拉霉素组,总有效率分别为82.1%和66.7%;莫西沙星组幽门螺杆菌根治率明显高于克拉霉素组,分别为89.7%和52.8%,差异均有统计学意义(P<0.05);克拉霉素组治疗失败后再接受莫西沙星组方案进行治疗,幽门螺杆菌根治率为87.5%。结论:莫西沙星根除幽门螺杆菌十分有效,治疗成功率高,作为补救治疗方案根治率也较高,值得在临床上推广。
作者 张启连
出处 《吉林医学》 CAS 2013年第6期1093-1094,共2页 Jilin Medical Journal
  • 相关文献

参考文献7

二级参考文献33

  • 1Cattoir V, Nectoux J, Lascols C, et al. Update on fluoroquinolone resistance in Helicobaeter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility[J]. Int J Antimierob Agents, 2007, 29(4): 389-396.
  • 2Cheon JH, Kim N, Lee DH, et al. Efficacy of moxifloxacin- based triple therapy as second-line treatment for Helicobacter pylori infection [J]. Helicobacter, 2006, 11(1): 46-51.
  • 3Nista EC, Candelli M. Moxifloxaein-based strategies for first-line treatment of Helicobacter pylori infection[J]. AlimentPharmacol Ther, 2005, 21(10): 1241-1247.
  • 4Saccoa F, Spezzaferroa M, Amitranoa M, et al. Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment[J]. Dig Liv Dis, 2010, 42(2): 110-114.
  • 5Javier P G, Leticia G, Xavier C. Systematic review and meta-analysis: proton pump inhibitor vs ranitidine bismuth citrate plus two antibiotics in Helicobacterpylori eradication [J]. Helicobacter, 2005, 10 (3): 157-171.
  • 6Di Cam S,Ojetti V,Zocco MA,et al.Mono,dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication[J].Aliment Phannacol Ther,2002,16(3):527-532.
  • 7Nista EC,Candelli M,Zocco MA,et al.Moxifloxaeinbased strategies for irst-line treatment of Helicobacter pyloft infection[J].Aliment Phannacol Ther,2005,21(10):1241-1247.
  • 8胡明礼.国内莫西沙星不良反应文献分析[J].药学服务与研究,2007,7(4):281-283. 被引量:41
  • 9成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 10Di Caro S, Ojetti V, Zocco MA, Cremonini F, Bartolozzi F, Candelli M, Lupascu A, Nista EC, Cammarota G, Gasbarrini A. Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16: 527-532.

共引文献26

同被引文献33

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部